HUE056301T2 - Szubsztituált karbamidszármazék és annak gyógyászatban történõ alkalmazása - Google Patents
Szubsztituált karbamidszármazék és annak gyógyászatban történõ alkalmazásaInfo
- Publication number
- HUE056301T2 HUE056301T2 HUE18831929A HUE18831929A HUE056301T2 HU E056301 T2 HUE056301 T2 HU E056301T2 HU E18831929 A HUE18831929 A HU E18831929A HU E18831929 A HUE18831929 A HU E18831929A HU E056301 T2 HUE056301 T2 HU E056301T2
- Authority
- HU
- Hungary
- Prior art keywords
- medicine
- salt
- urea derivative
- substituted urea
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/14—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710569633 | 2017-07-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE056301T2 true HUE056301T2 (hu) | 2022-02-28 |
Family
ID=65001137
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE18831929A HUE056301T2 (hu) | 2017-07-13 | 2018-07-11 | Szubsztituált karbamidszármazék és annak gyógyászatban történõ alkalmazása |
Country Status (11)
Country | Link |
---|---|
US (1) | US11213529B2 (hu) |
EP (1) | EP3652172B1 (hu) |
JP (1) | JP7202350B2 (hu) |
KR (1) | KR102566089B1 (hu) |
CN (1) | CN109251181B (hu) |
AU (1) | AU2018299536B2 (hu) |
CA (1) | CA3069773A1 (hu) |
DK (1) | DK3652172T3 (hu) |
ES (1) | ES2889749T3 (hu) |
HU (1) | HUE056301T2 (hu) |
WO (1) | WO2019011264A1 (hu) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022039421A1 (ko) * | 2020-08-18 | 2022-02-24 | 재단법인대구경북과학기술원 | 아베마시클립을 유효성분으로 포함하는 퇴행성 뇌질환의 예방 또는 치료용 약학적 조성물 |
CN112785582B (zh) * | 2021-01-29 | 2024-03-22 | 北京百度网讯科技有限公司 | 热力图生成模型的训练方法、装置、电子设备和存储介质 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005060969A1 (en) * | 2003-12-24 | 2005-07-07 | Astrazeneca Ab | Pyrimidines with tie2 (tek) activity |
ATE415970T1 (de) | 2003-12-24 | 2008-12-15 | Astrazeneca Ab | Pyrimidine mit tie2 (tek) aktivität |
GB0512324D0 (en) | 2005-06-16 | 2005-07-27 | Novartis Ag | Organic compounds |
GB0502418D0 (en) * | 2005-02-05 | 2005-03-16 | Astrazeneca Ab | Compounds |
CA2696776C (en) | 2007-09-19 | 2015-12-15 | Ambit Biosciences Corporation | Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith |
CN102153553A (zh) * | 2010-02-11 | 2011-08-17 | 山东轩竹医药科技有限公司 | 含有氨基磺酰胺基氮杂环丁烷的口服碳青霉烯化合物 |
HUE046008T2 (hu) | 2014-07-17 | 2020-02-28 | Sunshine Lake Pharma Co Ltd | I-(5-terc-butil)-izoxazol-3-il)-3-(4-((feniI)-etinil)-fenil)-kabamid származékok, valamint az ezekkel rokon vegyületek FLT-3 inhibitorokként rák kezelésére |
-
2018
- 2018-07-11 WO PCT/CN2018/095241 patent/WO2019011264A1/en unknown
- 2018-07-11 DK DK18831929.7T patent/DK3652172T3/da active
- 2018-07-11 ES ES18831929T patent/ES2889749T3/es active Active
- 2018-07-11 CN CN201810754363.2A patent/CN109251181B/zh active Active
- 2018-07-11 US US16/628,233 patent/US11213529B2/en active Active
- 2018-07-11 KR KR1020207004096A patent/KR102566089B1/ko active IP Right Grant
- 2018-07-11 EP EP18831929.7A patent/EP3652172B1/en active Active
- 2018-07-11 HU HUE18831929A patent/HUE056301T2/hu unknown
- 2018-07-11 AU AU2018299536A patent/AU2018299536B2/en active Active
- 2018-07-11 CA CA3069773A patent/CA3069773A1/en active Pending
- 2018-07-11 JP JP2020501260A patent/JP7202350B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
KR20200028442A (ko) | 2020-03-16 |
EP3652172A1 (en) | 2020-05-20 |
EP3652172A4 (en) | 2020-11-18 |
JP7202350B2 (ja) | 2023-01-11 |
CA3069773A1 (en) | 2019-01-17 |
WO2019011264A1 (en) | 2019-01-17 |
AU2018299536B2 (en) | 2022-06-02 |
DK3652172T3 (da) | 2021-09-20 |
CN109251181B (zh) | 2021-08-31 |
KR102566089B1 (ko) | 2023-08-14 |
US20200121690A1 (en) | 2020-04-23 |
CN109251181A (zh) | 2019-01-22 |
US11213529B2 (en) | 2022-01-04 |
AU2018299536A1 (en) | 2020-01-30 |
ES2889749T3 (es) | 2022-01-13 |
JP2020526550A (ja) | 2020-08-31 |
EP3652172B1 (en) | 2021-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL273918A (en) | Trispecific proteins and methods of use | |
HK1232224A1 (zh) | 取代脲衍生物及其在藥物中的應用 | |
IL249189A0 (en) | Combined treatment of antibodies against human cd40 and antibodies against human pd-l1 | |
HK1216251A1 (zh) | 吡唑並吡咯烷衍生物及其治病作用 | |
GB201616616D0 (en) | Nasal drug products and methods of their use | |
LT3786160T (lt) | Piridino dariniai ir jų terapinis panaudojimas kaip trpc6 inhibitorių | |
PL3004112T3 (pl) | Pochodne pirazolo-pirolidyn-4-onu oraz ich zastosowanie w leczeniu choroby | |
IL258978B (en) | The use of pyrimidine and pyridine derivatives in the treatment of multiple sclerosis | |
IL263969A (en) | Benzodioxane derivatives and their pharmaceutical use | |
EP3256461C0 (en) | UREA AND SULFONAMIDE DERIVATIVES AS HUMAN DDX3 HELICASE INHIBITORS USEFUL IN THE TREATMENT OF VIRAL DISEASES | |
GB201715194D0 (en) | Compounds and their therapeutic use | |
HK1248209A1 (zh) | 尿素衍生物和其用途 | |
ZA201805296B (en) | Succinate salt of cytisine and use thereof | |
HUE056301T2 (hu) | Szubsztituált karbamidszármazék és annak gyógyászatban történõ alkalmazása | |
IL261646A (en) | History of urea and amide and their use as cyclophilin inhibitors | |
ZA202000959B (en) | Adamantylmethylamine derivative and use thereof as pharmaceutical | |
HK1251558A1 (zh) | 新的酰亞胺衍生物及其作為藥物的用途 | |
HK1248208A1 (zh) | 尿素衍生物和其用途 | |
PL3262069T3 (pl) | Zastosowanie przeciwciał i antagonistów skierowanych przeciwko LRG1 w leczeniu | |
LT3152193T (lt) | Tetrahidroizochinolinono dariniai ir jų panaudojimas hsp70 baltymo inhibicijoje | |
AP2015008849A0 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of disease |